文献速递妇科

改善绝经泌尿生殖综合征的管理:基于健康系统的整群随机干预评估

Improving management of the genitourinary syndrome of menopause: evaluation of a health system-based, cluster-randomized intervention.
PubMed 文献 · Am J Obstet Gynecol · 2020-07-18

本研究采用整群随机设计,将16家初级保健诊所和6家妇科诊所分配至干预组或对照组,干预包括面对面临床培训、在线视频及电子健康记录中的临床决策支持工具。主要结局为2014年11月15日至2015年11月15日期间55岁及以上女性常规就诊时的外阴阴道诊断率,结果显示两组间外阴阴道诊断、泌尿系统诊断及阴道雌激素处方比例均无显著差异,但干预组临床医生使用决策支持工具的比例更高,妇科干预诊所的外阴阴道诊断显著多于初级保健干预诊所。

要点

  • 干预组与对照组的外阴阴道诊断比例无显著差异(7.2% vs 5.8%;OR 1.27;95%CI 0.65-2.51)。
  • 妇科干预诊所的外阴阴道诊断显著多于初级保健干预诊所(OR 1.63;95%CI 1.15-2.31)。
  • 干预组临床医生使用SmartSet(22.2% vs 1.5%;OR 18.8;95%CI 5.5-63.8)和SmartText(38.0% vs 24.4%;OR 1.91;95%CI 1.10-3.34)的比例均高于对照组。

核心结论

  • 总体而言,该干预未导致绝经后泌尿生殖症状的诊断或处方治疗增加,但使患者信息的分发增加。
  • 妇科临床医生更可能普遍处理泌尿生殖症状,并且在干预后更可能做出外阴阴道诊断。
  • 作者建议进一步改善护理的努力应考虑持续的临床医生教育,从住院医师培训中加强绝经课程开始;其他可考虑的干预措施包括增加绝经后女性获得妇科护理的机会、解决治疗障碍以及制定国家绩效指标。

研究设计与样本

  • 整群随机设计,将16家初级保健诊所和6家妇科诊所分配至干预组或对照组。
  • 干预包括2014年9月至11月在每家干预诊所进行面对面培训及在线视频,以及电子健康记录中的临床决策支持工具(基于证据的床旁知识资源、标准化医嘱集、患者教育材料清单)。
  • 主要结局为2014年11月15日至2015年11月15日期间55岁及以上女性常规就诊时做出的外阴阴道诊断。

主要发现

  • 在1年期间,386名临床医生为55岁及以上女性进行了14,921次常规就诊。
  • 干预诊所的190名进行常规就诊的临床医生中,109名(57.4%)完成了面对面或在线教育培训。
  • 外阴阴道诊断比例(7.2% vs 5.8%;OR 1.27;95%CI 0.65-2.51)、泌尿系统诊断比例(2.5% vs 3.1%;OR 0.79;95%CI 0.55-1.13)及阴道雌激素处方比例(4.5% vs 3.7%;OR 1.24;95%CI 0.63-2.46)在两组间均无显著差异。
  • 初级保健与妇科之间存在显著交互作用,妇科干预诊所的外阴阴道诊断多于初级保健干预诊所(OR 1.63;95%CI 1.15-2.31),但处方无显著交互作用。
  • 干预诊所的临床医生更可能使用决策支持工具:SmartSet(22.2% vs 1.5%;OR 18.8;95%CI 5.5-63.8)和SmartText患者信息(38.0% vs 24.4%;OR 1.91;95%CI 1.10-3.34);符合方案分析显示类似结果。

临床怎么用

  • 作者认为进一步改善护理的努力应考虑持续的临床医生教育,从住院医师培训中加强绝经课程开始。
  • 作者建议其他可考虑的干预措施包括增加绝经后女性获得妇科护理的机会、解决治疗障碍以及制定国家绩效指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genitourinary symptoms are common in postmenopausal women and adversely affect the quality of life. National surveys and data collected from our healthcare system indicate that postmenopausal women with the genitourinary syndrome of menopause often fail to receive appropriate diagnosis or treatment. OBJECTIVE: To promote greater detection and treatment of the genitourinary syndrome of menopause, we created and tested a clinician-focused health system intervention that included clinician education sessions and a suite of evidence-based electronic health record tools. STUDY DESIGN: Using a cluster-randomized design, we allocated primary care (16) and gynecology (6) clinics to the intervention or control group. From September to November 2014, we provided training about the diagnosis and treatment of genitourinary syndrome of menopause in face-to-face presentations at each intervention clinic and in an online video. We developed clinical decision support tools in the electronic health record that contained an evidence-based, point-of-care knowledge resource, a standardized order set, and a checklist of patient education materials for the patient's after visit summary. The tools aimed to facilitate accurate diagnostic coding and prescribing (SmartSet, SmartRx) along with relevant patient information (SmartText). Clinicians who only performed visits at control clinics received no training or notification about the tools. Our primary outcome was vulvovaginal diagnoses made at well visits for women at the age of 55 years and older from November 15, 2014 to November 15, 2015. We also assessed urinary diagnoses, vaginal estrogen prescriptions, and use of the electronic tools. There was departmental support for the intervention but no prioritization within the healthcare system to incentivize change. RESULTS: In the 1-year period, 386 clinicians performed 14,921 well visits for women at the age of 55 years and older. Among the 190 clinicians who performed well visits in the intervention clinics, 109 (57.4%) completed either in-person or online educational training. The proportion of visits that included a vulvovaginal (7.2% vs 5.8%; odds ratio, 1.27; 95% confidence interval, 0.65-2.51) or urinary diagnosis (2.5% vs 3.1%; odds ratio, 0.79; 95% confidence interval, 0.55-1.13) or vaginal estrogen prescription (4.5% vs 3.7%; odds ratio, 1.24; 95% confidence interval, 0.63-2.46) did not differ between study arms. There was a significant interaction for primary care and gynecology, which revealed more vulvovaginal diagnoses by gynecology but not primary care intervention clinics (odds ratio, 1.63; 95% confidence interval, 1.15-2.31), but there was no significant interaction for prescriptions. Clinicians in the intervention clinics were more likely to use decision support tools than those in control clinics-SmartSet (22.2% vs 1.5%; odds ratio, 18.8; 95% confidence interval, 5.5-63.8) and SmartText for patient information (38.0% vs 24.4%; odds ratio, 1.91; 95% confidence interval, 1.10-3.34). A per-protocol analysis revealed similar findings. CONCLUSION: Overall, the intervention did not lead to more diagnoses or prescription therapy for postmenopausal genitourinary symptoms but did result in greater distribution of patient information. Gynecology clinicians were more likely to address genitourinary symptoms generally and were more likely to make a vulvovaginal diagnosis after the intervention. Further efforts for improving care should consider ongoing clinician education beginning with enhanced menopause curricula in residency training. Additional interventions to consider include greater access for postmenopausal women to gynecologic care, addressing treatment barriers, and development of national performance metrics.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Vesco KK, Leo MC, Bulkley JE, et al. Improving management of the genitourinary syndrome of menopause: evaluation of a health system-based, cluster-randomized intervention. Am J Obstet Gynecol. 2020. PMID: 32693097. doi:10.1016/j.ajog.2020.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。